Cassava Sciences Inc (NASDAQ:SAVA) Expects To Release Clinical Results Of Phase...

Max - 0

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...

Max - 0

Vistagen Therapeutics Inc (NASDAQ:VTGN) Reaches A Consensus With FDA On PH94B...

Max - 0

Onconova Therapeutics Inc (NASDAQ:ONTX) Expects To Announce Topline Data Of Inspire...

Max - 0

Jaguar Health Inc (NASDAQ:JAGX) Posts A Growth Of 186% YoY In...

Max - 0

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Focuses On Developing SNS-510, The PDK-1 Inhibitor:...

Max - 0

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Will Publish First Data Of TNX-1800...

Max - 0

Aerpio Pharmaceuticals Inc (NASDAQ:ARPO) Commences Phase 2 Clinical Study To Assess...

Max - 0

Axovant Gene Therapies Ltd (NASDAQ:AXGT) Enters Manufacturing And Supply Agreement With...

Max - 0

Allena Pharmaceuticals Inc (NASDAQ:ALNA) Expands Clinical Trial Sites Of URIROX-2: Initiates...

Max - 0
1...199200201...248Page 200 of 248